About Im Cannabis
Im Cannabis (CNSX:IMCC), (NASDAQ:IMCC) is a multi-faceted company deeply rooted in the medical and adult-use recreational cannabis industry. The company is recognized for its commitment to quality, regulatory compliance, and innovative operations across its international footprint. IM Cannabis focuses on producing and distributing a wide array of cannabis products, aiming to meet the diverse needs of its customer base. Additionally, the company actively pursues research and development projects aimed at creating new cannabis varieties and product formulations, underscoring its dedication to industry advancement and customer satisfaction. Through strategic acquisitions and partnerships, IM Cannabis strives to expand its market presence and adapt to the evolving cannabis landscape, with the ultimate objective of delivering substantial value to consumers and stakeholders alike.
Snapshot
Operations
Products and/or services of Im Cannabis
- Medical cannabis products offering a range of marijuana strains for various therapeutic purposes.
- Recreational cannabis lines tailored for different user experiences and preferences.
- International export services facilitating the distribution of medical cannabis products to global markets.
- Cannabis genetics and cultivation research to develop unique strains and improve product quality.
- Pharmaceutical-grade processing facilities ensuring high-quality cannabis products.
- Cannabis education and advocacy programs promoting responsible use and awareness of the benefits of cannabis.
Im Cannabis executive team
- Mr. Oren ShusterCEO & Executive Director
- Advocate Michal Lebovitz NissimovGeneral Counsel & Secretary
- Mr. Richard BallaChief Executive Officer of Adjupharm
- Mr. Eyal FisherChief Executive Officer of the IMC Holdings
- Mr. Asi LeviChief Financial Officer
- Anna TarankoDirector Investor & Public Relations